文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

非创伤性院外心脏骤停复苏患者的衰弱与神经功能结局:一项前瞻性观察研究

Frailty and Neurologic Outcomes of Patients Resuscitated From Nontraumatic Out-of-Hospital Cardiac Arrest: A Prospective Observational Study.
PubMed 文献 · Ann Emerg Med · 2023-03-23
一句话结论院外心脏骤停复苏后入住ICU的患者中,骤停前临床衰弱量表评分≥5分与30天不良神经功能结局独立相关(调整OR 0.45)。

这项前瞻性多中心观察研究纳入2019至2021年非创伤性院外心脏骤停经ROSC后入住ICU的成人患者,骤停前临床衰弱量表评分≥5分定义为高衰弱。共1,216例纳入,其中317例为高评分;高评分组30天脑功能分级(CPC)≤2分的有利神经结局比例低于低评分组(6.1% vs 24.4%),调整OR 0.45(95%CI 0.22–0.93)。亚组分析显示该关联在心源性骤停、到院后ROSC及死亡高风险较低(评分≤7分)者中持续存在,而在非心源性骤停及到院前ROSC者中神经结局相当。结论提示骤停前临床衰弱量表评分有助于预测ROSC后ICU治疗的临床结局。

要点

  • 骤停前临床衰弱量表评分≥5分的OHCA复苏后ICU患者,30天有利神经结局(CPC≤2分)为6.1%,低于低评分组的24.4%(调整OR 0.45,95%CI 0.22–0.93)。
  • 该关联在心源性OHCA、到院后ROSC、临床衰弱量表评分≤7分的亚组中持续存在。
  • 非心源性OHCA及到院前ROSC患者中,神经结局在衰弱高评分与低评分组间相当。
  • 临床衰弱量表评分有助于预测ROSC后ICU治疗的临床结局。

适用人群与场景

  • 2019至2021年纳入的非创伤性院外心脏骤停、经ROSC后入住ICU的成人患者。

诊断标准与关键阈值

  • 骤停前高临床衰弱量表评分定义为5分或以上。
  • 有利神经结局定义为入院后30天脑功能分级(CPC)评分2分或以下。

研究设计与关键结果

  • 研究类型为前瞻性、多中心、观察性研究,研究期间共9,909例OHCA患者,最终纳入1,216例,其中317例骤停前临床衰弱量表评分≥5分。
  • 高临床衰弱量表评分组有利神经结局比例低于低评分组(6.1% vs 24.4%;调整OR 0.45,95%CI 0.22–0.93)。
  • 亚组分析显示,该关联在心源性OHCA、到院后ROSC、以及死亡高风险较低(临床衰弱量表评分≤7分)的患者中持续存在;而在非心源性OHCA和到院前ROSC患者中,无论骤停前衰弱状态如何,神经结局相当。

证据类型、等级与局限

  • 证据类型:前瞻性、多中心、观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床衰弱量表评分有助于预测ROSC后ICU治疗的临床结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: To elucidate the clinical utility of the Clinical Frailty Scale score for predicting poor neurologic functions in patients resuscitated from out-of-hospital cardiac arrest (OHCA).

METHODS: This was a prospective, multicenter, observational study conducted between 2019 and 2021. The study included adults with nontraumatic OHCA admitted to the intensive care unit after return of spontaneous circulation (ROSC). Pre-arrest high Clinical Frailty Scale score was defined as 5 or more. Favorable neurologic outcomes defined as a Cerebral Performance Category score of 2 or less at 30 days after admission were compared between patients with and without high Clinical Frailty Scale scores. Multivariable logistic regression analyses fitted with generalized estimating equations were performed to adjust for patient characteristics, out-of-hospital information, and resuscitation content and account for within-institution clustering.

RESULTS: Of 9,909 patients with OHCA during the study period, 1,216 were included, and 317 had a pre-arrest high Clinical Frailty Scale score. Favorable neurologic outcomes were fewer among patients with high Clinical Frailty Scale scores. The high Clinical Frailty Scale score group showed a lower percentage of favorable neurologic outcomes after OHCA than the low Clinical Frailty Scale score group (6.1% vs 24.4%; adjusted odds ratio, 0.45 [95% confidence interval 0.22 to 0.93]). This relationship remained in subgroups with cardiogenic OHCA, with ROSC after hospital arrival, and without a high risk of dying (Clinical Frailty Scale score of 7 or less), whereas the neurologic outcomes were comparable regardless of pre-arrest frailty in those with noncardiogenic OHCA and with ROSC before hospital arrival.

CONCLUSIONS: Pre-arrest high Clinical Frailty Scale score was associated with unfavorable neurologic functions among patients resuscitated from OHCA. The Clinical Frailty Scale score would help predict clinical consequences following intensive care after ROSC.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Yamamoto R, Tamura T, Haiden A, et al. Frailty and Neurologic Outcomes of Patients Resuscitated From Nontraumatic Out-of-Hospital Cardiac Arrest: A Prospective Observational Study. Ann Emerg Med. 2023. PMID: 36964008. doi:10.1016/j.annemergmed.2023.02.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。